For the health and safety of the Grand Valley community, remote academic instruction will continue through June 17. The Admissions office is available to answer calls Mon.-Fri. from 8 a.m. to 5 p.m. at (616) 331-2025 or (800) 748-0246 or email firstname.lastname@example.org. Additional instructions and updates at www.gvsu.edu/coronavirus
We are devoted to the betterment of human health and well-being through applied medical device innovation
Enhancing student learning experiences, engaging faculty and our community to bring novel medical devices to market
Medical device development begins with an idea. The idea, often in the form of a napkin sketch, must cross a ‘development valley-of-death’. Med device development requires a broad range of science, engineering, and business resources. applied Medical Device Institute (aMDI) serves the med device community as a means to cross the development valley-of-death, by providing access to researchers, engineers, medical professionals, business and entrepreneurial expertise within an integrated process that includes technical services, intellectual property, business review and mentoring.
aMDI provides a full range of services, including but not limited to: developing analytical and physical models; rapid prototyping and fabricating systems; comprehensive testing for technical feasibility; and incubator space. aMDI addresses business and market viability issue in collaboration with other entrepreneurial, regulatory, investment, and business architecture entities. Commercialization is facilitated at aMDI by connecting to the region's existing commercialization and financing organizations. In addition to the physicians, nurses, and clinicians, aMDI serves small companies as a contract “R&D department” and large companies by providing responsive intellectual capacity to meet the demands of unforeseen business cycles or emerging technologies.
aMDI differentiates itself with an applied focus, where proof-of-principle and go/no-go criteria are balanced with risk mitigation plan. This approach provides expedient response-models cost (high value) for early concept development and proof of concept delivery, if technically and commercially viable.
Featured Team Member of the Month
PREYAN CHOUDHURI, HEALTH SCIENCES AND ENGINEERING MARKETING SPECIALIST
Describe your role at aMDI.
As a Health Sciences & Engineering Marketing Specialist, I developed and implemented marketing strategies to strengthen aMDI’s brand recognition in the health sciences sector. My job was bilateral; I generated awareness about aMDI’s services, as well as, provided marketing assistance to aMDI’s clients.
What has been your favorite part about working at aMDI?
The people. This has been a very fun, supportive and creative team to work with. They made me look forward to coming to office.
Read more about Preyan in her Employee of the Month Interview HERE
February 05, 2019
The partners said toxicity of the materials historically has made 3D printing of polymer-based medical device components impossible, but Carbon's technology uses nine nontoxic families of materials.
January 24, 2019
"Our study is looking at the threshold where 3D printing is the best option versus using traditional manufacturing methods like injection molding and CNC Machining," said Nowak, about the grant awarded last year.
January 24, 2019
A state-of-the-art 3D printer from Carbon, Inc. has been installed at the Padnos College of Engineering & Computing on the Medical Mile, letting students take part in real-world experiments.
January 22, 2019
Grand Valley State University (GVSU) and the applied Medical Device Institute (aMDI) in Michigan have been awarded half a million dollars for a two-and-a-half year medical 3D printing study.
January 22, 2019
Food and Drug Administration-approved materials are used in the process, and the method doesn't require the injection molds and other components used in traditional manufacturing.